Journal article
Morpholino-driven gene editing: a new horizon for disease treatment and prevention
Clinical pharmacology and therapeutics, Vol.99(1), pp.21-25
01/2016
DOI: 10.1002/cpt.276
PMCID: PMC4720544
PMID: 26474085
Abstract
The development of genetic and molecular biology tools permitting the connection of specific genes to their functions has accelerated our understanding of molecular pathways underlying health and disease. The resulting gains in knowledge have propelled gene targeting to the forefront of promising therapeutic strategies. Here we discuss the uniquely powerful and adaptable approach of morpholino-driven modification of normal and mutant gene expression as a pathway to health.
Details
- Title: Subtitle
- Morpholino-driven gene editing: a new horizon for disease treatment and prevention
- Creators
- Ekaterina Subbotina - Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, USASiva Rama Krishna Koganti - Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, USADenice Hodgson-Zingman - Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, USALeonid V Zingman - Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, USA
- Resource Type
- Journal article
- Publication Details
- Clinical pharmacology and therapeutics, Vol.99(1), pp.21-25
- DOI
- 10.1002/cpt.276
- PMID
- 26474085
- PMCID
- PMC4720544
- NLM abbreviation
- Clin Pharmacol Ther
- ISSN
- 0009-9236
- eISSN
- 1532-6535
- Grant note
- DOI: 10.13039/100000002, name: National Institutes of Health, award: HL113089 to D. Hodgson-Zingman [University of Iowa, DK092412 to L. Zingman [University of Iowa; name: VA Merit Review Program, award: 1I0BX000718 to L. Zingman [University of Iowa
- Language
- English
- Date published
- 01/2016
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Cardiovascular Medicine; Internal Medicine
- Record Identifier
- 9984094211602771
Metrics
18 Record Views